These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 18165630)

  • 1. Reflections on medical oncology: 25 years of clinical trials--where have we come and where are we going?
    Booth CM; Tannock I
    J Clin Oncol; 2008 Jan; 26(1):6-8. PubMed ID: 18165630
    [No Abstract]   [Full Text] [Related]  

  • 2. Society of Interventional Radiology Interventional Oncology Task Force: interventional oncology research vision statement and critical assessment of the state of research affairs.
    Goldberg SN; Bonn J; Dodd G; Dupuy D; Geschwind JH; Hicks M; Hume KM; Lee FT; Lewis CA; Lencioni RA; Omary RA; Rundback JH; Silverman S; Dorfman GS;
    J Vasc Interv Radiol; 2005 Oct; 16(10):1287-94. PubMed ID: 16221897
    [No Abstract]   [Full Text] [Related]  

  • 3. The scientific basis of clinical trials: statistical aspects.
    Gehan EA
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2587-90. PubMed ID: 9815661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reflections on medical oncology: an appeal for better clinical trials and improved reporting of their results.
    Tannock I; Murphy K
    J Clin Oncol; 1983 Jan; 1(1):66-70. PubMed ID: 6668484
    [No Abstract]   [Full Text] [Related]  

  • 5. Highlights from the 29th European Society for Medical Oncology Congress: Vienna, Austria, October 29 through November 2, 2004.
    Price N
    Clin Prostate Cancer; 2004 Dec; 3(3):136-40. PubMed ID: 15636678
    [No Abstract]   [Full Text] [Related]  

  • 6. Improving the institutional submission and approval process for clinical research protocols in oncology.
    Camacho LH; Marubio L; Purdom MA; Leonard D; Hong DS; Moulder S; Pilat SR; Kurzrock R
    J Clin Oncol; 2007 Apr; 25(12):1632-3. PubMed ID: 17443009
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results of questionnaire to 56 medical institutions about clinical trials of cancer chemotherapy].
    Kurihara M; Matsukawa M; Satoh A; Shimada K; Asaumi H
    Gan To Kagaku Ryoho; 1999 Jun; 26(7):916-25. PubMed ID: 10396318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phase III candidate: can we improve the science of selection?
    Bajorin D
    J Clin Oncol; 2004 Jan; 22(2):211-3. PubMed ID: 14665614
    [No Abstract]   [Full Text] [Related]  

  • 9. [Critical reading of a clinical trial in oncopneumology].
    Kreisman H; Charloux A
    Rev Pneumol Clin; 1994; 50(1):1-2. PubMed ID: 7973325
    [No Abstract]   [Full Text] [Related]  

  • 10. Long overdue: phase II studies in older cancer patients: where does the FDA stand?
    Balducci L; Tam-McDevitt J; Hauser R; Simon J
    J Clin Oncol; 2008 Mar; 26(8):1387-88. PubMed ID: 18323564
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of measurement error on response rates.
    Warr D; McKinney S; Tannock I
    Cancer Treat Rep; 1985 Oct; 69(10):1127-32. PubMed ID: 4042092
    [No Abstract]   [Full Text] [Related]  

  • 12. Computer-aided documentation and therapy planning in pediatric oncology.
    Wiedemann T; Knaup P; Bachert A; Creutzig U; Haux R; Schilling F
    Stud Health Technol Inform; 1998; 52 Pt 2():1306-9. PubMed ID: 10384671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An efficient design for phase III studies of combination chemotherapies.
    Ellenberg SS; Eisenberger MA
    Cancer Treat Rep; 1985 Oct; 69(10):1147-54. PubMed ID: 4042093
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancer clinical trials: the emergence and development of a new style of practice.
    Keating P; Cambrosio A
    Bull Hist Med; 2007; 81(1):197-223. PubMed ID: 17369668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Geriatric oncology aims for clinical trials.
    Sinha G
    J Natl Cancer Inst; 2006 Nov; 98(21):1516-8. PubMed ID: 17077352
    [No Abstract]   [Full Text] [Related]  

  • 16. [Active studies of the Working Association for Urological Oncology (AUO) in 2006].
    Rexer H
    Urologe A; 2006 Feb; 45(2):229-40. PubMed ID: 16440204
    [No Abstract]   [Full Text] [Related]  

  • 17. Health care disparity: an overlooked problem in phase I oncology trials.
    O'Brien TE
    J Clin Oncol; 2007 Jul; 25(21):3182-3. PubMed ID: 17634502
    [No Abstract]   [Full Text] [Related]  

  • 18. The changing landscape of urologic oncology: initiating systemic therapies, interventional skills, and clinical trials. Introduction.
    Lin DW; Shore ND
    Urol Oncol; 2012; 30(4 Suppl):S1. PubMed ID: 22795074
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost effectiveness, chemotherapy, and the clinician.
    Griggs JJ; Sorbero ME
    Breast Cancer Res Treat; 2009 Apr; 114(3):597-8. PubMed ID: 18695985
    [No Abstract]   [Full Text] [Related]  

  • 20. A positive step forward, but more needed to maximize cost benefits of new-generation cancer therapies.
    Haines IE
    J Clin Oncol; 2007 Sep; 25(25):e31-2. PubMed ID: 17761966
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.